| Vial description: |
Acidic complement C4, Basic complement C4, CPAMD2, CPAMD3, Complement component 4 |
| Category: |
primary antibody |
| Raised in: |
Goat |
| Clone: |
1 vial |
| Form: |
Serum |
| Reactivity: |
Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P0C0L4 |
| Application: |
IP |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
Complement C4A/C4B |
| Short name: |
anti-Complement C4A/C4B Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
antibody to-Complement complement component 4A (Rodgers blood group)/complement component 4B (Chido blood group) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
C4 and C4A2 and C4A3 and C4A4 and C4A6 and C4AD and C4S and CO4 and CPAMD2 and RG, C4A and IDBG-125942 and ENSG00000244731 and 720, C4B and IDBG-301132 and ENSG00000224389 and 100293534, C4B_2 and C4B1 and C4B12 and C4B2 and C4B3 and C4B5 and C4BD and C4F and CH and CO4 and CPAMD3, Extracellular, Extracellular, carbohydrate binding, classical pathway and biological process this GO :0008228 and opsonization and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0030246 and carbohydrate binding and molecular function this GO :0030449 and regulation of complement activation and biological process this GO :0032490 and detection of molecule of bacterial origin and biological process this GO :0044216 and other organism cell and cellular component this GO :0045087 and innate immune response and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component this GO :2000427 and positive regulation of apoptotic cell clearance and biological process, classical pathway and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0030449 and regulation of complement activation and biological process this GO :0045087 and innate immune response and biological process this GO :0072562 and blood microparticle and cellular component this GO :2000427 and positive regulation of apoptotic cell clearance and biological process, complement component 4B (Chido blood group), protein binding, this GO :0001848 and complement binding and molecular function this GO :0004866 and endopeptidase inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006954 and inflammatory response and biological process this GO :0006956 and complement activation and biological process this GO :0006958 and complement activation, this GO :0001848 : complement binding, this GO :0001848 : complement binding and also this GO :0004866 : endopeptidase inhibitor activity and also this GO :0005515 : protein binding and also this GO :0030246 : carbohydrate binding, this GO :0001849 and complement component C1q binding and molecular function this GO :0004866 and endopeptidase inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006954 and inflammatory response and biological process this GO :0006956 and complement activation and biological process this GO :0006958 and complement activation, this GO :0001849 : complement component C1q binding, this GO :0001849 : complement component C1q binding and also this GO :0004866 : endopeptidase inhibitor activity and also this GO :0005515 : protein binding, this GO :0004866 : endopeptidase inhibitor activity, this GO :0004866 : endopeptidase inhibitor activity, this GO :0005515 : protein binding, this GO :0005515 : protein binding, this GO :0030246 : carbohydrate binding, 721, complement component 4A (Rodgers blood group) |
| Identity: |
1323 |
| Gene: |
C4A |
More about : C4A |
| Long gene name: |
complement C4A (Rodgers blood group) |
| Synonyms gene name: |
complement component 4A complement component 4A (Rodgers blood group) |
| Synonyms: |
CPAMD2 C4S CO4 C4 C4A3 C4A2 C4A4 C4A6 C4B RG |
| Locus: |
6p21, 33 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
L26261 M14823 X77491 AY224378 |
| Entrez gene record: |
720 |
| RefSeq identity: |
NM_007293 |
| Classification: |
Complement system Blood group antigens C3 and PZP like, alpha-2-macroglobulin domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000031186 |
| Locus Specific Databases: |
LRG_137 |